Compulsory Licensing under TRIPS: The Negotiations
TRIPS AND COMPULSORY LICENSING: INCREASING PARTICIPATION IN THE MEDICINES PATENT POOL IN THE WAKE OF AN HIV/AIDS TREATMENT TIMEBOMB
34
Compulsory licensing and access to drugs
26
Compulsory licensing and access to drugs
26
From the TRIPS Agreement to the Public Health Declaration---On the New Development of the International Compulsory Patent Licensing System and Its Impact
17
Compulsory Licensing of Patents: the Bayer-Natco Case
14
Current Scenario of Patent Act: Compulsory Licensing
5
The role compulsory licensing in combatting counterfeit drugs in Nigeria
33
Saving Tomorrow from Today: Preserving Innovation in the Face of Compulsory Licensing
44
Compulsory Licensing of Pharmaceuticals Patent in Developing Nations:-Legal Issues and Challenges
11
Compulsory licensing of Standard Essential Patents to remedy abuses of dominant position
332
Restricting the Use of an Intellectual Property Right – The Cross-Atlantic View on Compulsory Licensing
41
A precautionary approach to compulsory licensing and tempering the data exclusivity obstacle for access to medicines
17
Could international compulsory licensing reconcile tiered pricing of pharmaceuticals with the right to health?
9
Compulsory patent licensing and access to essential medicines in developing countries after the Doha Declaration
289
History of evolution of compulsory licensing is one of the least explored areas of intellectual property law
18
Flexibilities under Trips: Implementation Gaps between Theory and Practice
26
Compulsory Licensing And Statutory Licensing
10
The Application of Intellectual Property Compulsory Licensing in Antitrust
17
COMPULSORY LICENSING OF PHARMACEUTICAL PATENTS IN INDIA: A RESEARCH STUDY
12
Static inefficiency of compulsory licensing: Quantity vs. price competition.
27